$ABBV
AbbVie Inc.

2020 Q1 Form 10-Q Financial Statement

#000155115220000015 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $8.619B $7.828B $8.305B
YoY Change 10.1% -1.34% 7.31%
Cost Of Revenue $1.942B $1.694B $2.005B
YoY Change 14.64% -12.09% -12.71%
Gross Profit $6.677B $6.134B $6.283B
YoY Change 8.85% 2.11% 15.12%
Gross Profit Margin 77.47% 78.36% 75.65%
Selling, General & Admin $1.695B $1.680B $1.929B
YoY Change 0.89% -6.2% -1.13%
% of Gross Profit 25.39% 27.39% 30.7%
Research & Development $1.379B $1.289B $1.395B
YoY Change 6.98% 3.62% -0.5%
% of Gross Profit 20.65% 21.01% 22.2%
Depreciation & Amortization $115.0M $118.0M $442.0M
YoY Change -2.54% 2.61% 19.78%
% of Gross Profit 1.72% 1.92% 7.03%
Operating Expenses $3.074B $2.969B $3.324B
YoY Change 3.54% -2.17% -0.86%
Operating Profit $3.603B $3.010B $2.959B
YoY Change 19.7% 3.69% 40.57%
Interest Expense $563.0M $387.0M -$342.0M
YoY Change 45.48% 25.24% -42.62%
% of Operating Profit 15.63% 12.86% -11.56%
Other Income/Expense, Net -$72.00M -$135.0M $393.0M
YoY Change -46.67% -188.24% 3175.0%
Pretax Income $3.098B $2.544B -$2.373B
YoY Change 21.78% -9.05% -298.91%
Income Tax $88.00M $88.00M -$633.0M
% Of Pretax Income 2.84% 3.46%
Net Earnings $3.010B $2.456B -$1.826B
YoY Change 22.56% -11.75% -3611.54%
Net Earnings / Revenue 34.92% 31.37% -21.99%
Basic Earnings Per Share $2.02 $1.65 -$1.23
Diluted Earnings Per Share $2.02 $1.65 -$1.23
COMMON SHARES
Basic Shares Outstanding 1.481B shares 1.480B shares 1.504B shares
Diluted Shares Outstanding 1.484B shares 1.483B shares

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.14B $5.228B $8.061B
YoY Change 686.95% -44.82% -17.65%
Cash & Equivalents $41.14B $4.897B $7.289B
Short-Term Investments $331.0M $772.0M
Other Short-Term Assets $2.410B $1.803B $1.895B
YoY Change 33.67% -46.83% -60.03%
Inventory $1.844B $1.702B $1.605B
Prepaid Expenses
Receivables $6.362B $5.680B $5.384B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $51.76B $14.41B $16.95B
YoY Change 259.11% -29.5% -20.16%
LONG-TERM ASSETS
Property, Plant & Equipment $2.961B $2.860B $2.883B
YoY Change 3.53% 1.13% 2.85%
Goodwill $15.56B $15.61B $15.66B
YoY Change -0.29% -1.73% -0.77%
Intangibles $18.20B $20.85B $21.23B
YoY Change -12.68% -23.44% -22.95%
Long-Term Investments $78.00M $1.477B $1.420B
YoY Change -94.72% -28.2% -32.06%
Other Assets $2.638B $1.567B $1.208B
YoY Change 68.35% 73.53% -8.9%
Total Long-Term Assets $39.44B $42.36B $42.41B
YoY Change -6.88% -13.38% -14.44%
TOTAL ASSETS
Total Short-Term Assets $51.76B $14.41B $16.95B
Total Long-Term Assets $39.44B $42.36B $42.41B
Total Assets $91.20B $56.77B $59.35B
YoY Change 60.65% -18.13% -16.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.70B $11.67B $1.546B
YoY Change 8.8% 10.59% 4.88%
Accrued Expenses $110.0M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $6.000M $499.0M $3.699B
YoY Change -98.8% 35.97% 824.75%
Long-Term Debt Due $3.756B $1.579B $1.609B
YoY Change 137.87% -73.74% -73.25%
Total Short-Term Liabilities $16.47B $13.90B $17.24B
YoY Change 18.46% -18.49% 3.59%
LONG-TERM LIABILITIES
Long-Term Debt $63.28B $35.07B $35.00B
YoY Change 80.47% 13.46% 13.08%
Other Long-Term Liabilities $17.90B $14.51B $1.307B
YoY Change 23.37% -6.52% 5.32%
Total Long-Term Liabilities $17.90B $49.58B $1.307B
YoY Change -63.89% 6.78% 5.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.47B $13.90B $17.24B
Total Long-Term Liabilities $17.90B $49.58B $1.307B
Total Liabilities $34.37B $64.60B $18.55B
YoY Change -46.79% -1.81% 3.71%
SHAREHOLDERS EQUITY
Retained Earnings $5.973B $4.234B $3.368B
YoY Change 41.07% -14.93% -38.3%
Common Stock $15.40B $14.94B $14.76B
YoY Change 3.09% 2.9% 3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $25.11B $24.50B $24.11B
YoY Change 2.48% 83.8% 102.2%
Treasury Stock Shares 309.6M shares 302.6M shares 297.7M shares
Shareholders Equity -$7.415B -$7.826B -$8.446B
YoY Change
Total Liabilities & Shareholders Equity $91.20B $56.77B $59.35B
YoY Change 60.65% -18.13% -16.15%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income $3.010B $2.456B -$1.826B
YoY Change 22.56% -11.75% -3611.54%
Depreciation, Depletion And Amortization $115.0M $118.0M $442.0M
YoY Change -2.54% 2.61% 19.78%
Cash From Operating Activities $3.815B $3.017B $3.392B
YoY Change 26.45% 14.06% 31.27%
INVESTING ACTIVITIES
Capital Expenditures $125.0M $107.0M -$123.0M
YoY Change 16.82% -10.08% -32.42%
Acquisitions
YoY Change
Other Investing Activities $5.000M $0.00 -$160.0M
YoY Change -100.0% -141.78%
Cash From Investing Activities -$129.0M -$27.00M -$283.0M
YoY Change 377.78% -93.96% -240.8%
FINANCING ACTIVITIES
Cash Dividend Paid $1.763B $1.588B
YoY Change 11.02% 39.67%
Common Stock Issuance & Retirement, Net $643.0M $620.0M
YoY Change 3.71% -56.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.422B -$5.383B -3.825B
YoY Change -55.01% 114.55% 98.39%
NET CHANGE
Cash From Operating Activities $3.815B $3.017B 3.392B
Cash From Investing Activities -$129.0M -$27.00M -283.0M
Cash From Financing Activities -$2.422B -$5.383B -3.825B
Net Change In Cash $1.218B -$2.392B -716.0M
YoY Change -150.92% 669.13% -183.55%
FREE CASH FLOW
Cash From Operating Activities $3.815B $3.017B $3.392B
Capital Expenditures $125.0M $107.0M -$123.0M
Free Cash Flow $3.690B $2.910B $3.515B
YoY Change 26.8% 15.2% 27.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 abbv Other Comprehensive Income Loss Net Investment Hedge Tax Portion Attributableto Parent
OtherComprehensiveIncomeLossNetInvestmentHedgeTaxPortionAttributabletoParent
19000000 USD
CY2020Q1 abbv Other Comprehensive Income Loss Net Investment Hedge Tax Portion Attributableto Parent
OtherComprehensiveIncomeLossNetInvestmentHedgeTaxPortionAttributabletoParent
20000000 USD
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001551152
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1781582608 shares
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-2000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-30000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-101000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2909000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2420000000 USD
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1786240964 shares
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.03
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 USD
CY2019Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2019Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2020Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-6000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-15000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
1000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
-8000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-7000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-2000000 USD
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
302671146 shares
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
309566303 shares
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-35565
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
AbbVie Inc.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0375147
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1 North Waukegan Road
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
North Chicago
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60064-6400
CY2020Q1 dei City Area Code
CityAreaCode
847
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
932-7900
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1476742215 shares
CY2020Q1 us-gaap Revenues
Revenues
8619000000 USD
CY2019Q1 us-gaap Revenues
Revenues
7828000000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1942000000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1694000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1695000000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1680000000 USD
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1379000000 USD
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1289000000 USD
CY2020Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
CY2019Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
155000000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
5016000000 USD
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
4818000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3603000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3010000000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-428000000 USD
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-325000000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-72000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-135000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3098000000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2544000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3010000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2456000000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.65
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.02
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1481000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1480000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1484000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1483000000 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3010000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2456000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-227000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-103000000 USD
CY2020Q1 abbv Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax Portion Attributableto Parent
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTaxPortionAttributabletoParent
72000000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
1844000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41142000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39924000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6362000000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5428000000 USD
CY2019Q1 abbv Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax Portion Attributableto Parent
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTaxPortionAttributabletoParent
65000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-56000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-25000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1813000000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2410000000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2354000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
51758000000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
49519000000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
78000000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
93000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2961000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2962000000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18203000000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18649000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
15561000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
15604000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2638000000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2288000000 USD
CY2020Q1 us-gaap Assets
Assets
91199000000 USD
CY2019Q4 us-gaap Assets
Assets
89115000000 USD
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
6000000 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3756000000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3753000000 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12709000000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11832000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16471000000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15585000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
63284000000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
62975000000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
959000000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1130000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17900000000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17597000000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
18000000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
18000000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
25110000000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24504000000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15401000000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15193000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5973000000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3596000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-7415000000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4717000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3697000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8172000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91199000000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89115000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-8446000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2456000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1590000000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
419000000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
209000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-7826000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8172000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3010000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-101000000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1754000000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
643000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
245000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-7415000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3010000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2456000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
115000000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
118000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
444000000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385000000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
72000000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
169000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
219000000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
189000000 USD
CY2020Q1 abbv Upfront Costs Related To Collaborations
UpfrontCostsRelatedToCollaborations
40000000 USD
CY2019Q1 abbv Upfront Costs Related To Collaborations
UpfrontCostsRelatedToCollaborations
195000000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 USD
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
33000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1025000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
316000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
107000000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
128000000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19000000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
112000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1065000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
94000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3815000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3017000000 USD
CY2020Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
12000000 USD
CY2019Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
320000000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
125000000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
107000000 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
13000000 USD
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
194000000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
26000000 USD
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
594000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5000000 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-129000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27000000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-200000000 USD
CY2020Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
0 USD
CY2019Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
3000000000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1763000000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1588000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
643000000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
620000000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000000 USD
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
53000000 USD
CY2019Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
25000000 USD
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
21000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2422000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5383000000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-46000000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1218000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2392000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39924000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7289000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41142000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4897000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
563000000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
387000000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
135000000 USD
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
62000000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-428000000 USD
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-325000000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
546000000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
485000000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
932000000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
942000000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
366000000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
386000000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
1844000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1813000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8250000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8188000000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5289000000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5226000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2961000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2962000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
115000000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
118000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3010000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2456000000 USD
CY2020Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
14000000 USD
CY2019Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
12000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2996000000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2444000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1481000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1480000000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.65
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3010000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2456000000 USD
CY2020Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
14000000 USD
CY2019Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
12000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2996000000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2444000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1481000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1480000000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1484000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1483000000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.02
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
57000000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
132000000 USD
CY2019Q2 us-gaap Share Price
SharePrice
78.45
CY2020Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
12000000 USD
CY2019Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
320000000 USD
CY2020Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
CY2019Q1 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
155000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
15604000000 USD
CY2020Q1 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-43000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
15561000000 USD
CY2020Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-72000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27336000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9133000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18203000000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27345000000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8696000000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18649000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
444000000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385000000 USD
CY2020Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
17000000 USD
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
167000000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
140000000 USD
CY2020Q1 abbv Restructuring Reserve Cash Settled Restructuring Gains Losses
RestructuringReserveCashSettledRestructuringGainsLosses
-17000000 USD
CY2020Q1 abbv Restructuring Reserve Period Cash Settled And Other Adjustments
RestructuringReservePeriodCashSettledAndOtherAdjustments
38000000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
119000000 USD
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
235000000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
53000000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7340000000 USD
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4483000000 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-169000000 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
53000000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7359000000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4652000000 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
75000000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
66000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
0 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
219000000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
189000000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
39000000 USD
CY2019Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
33000000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
180000000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
156000000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.18
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.18
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.07
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.07
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.07
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3500000000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.03
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
50000000 USD
CY2020Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
300000000 USD
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
290000000 USD
CY2020Q1 abbv Percentageof Claims Subjectto Settlement Agreements
PercentageofClaimsSubjecttoSettlementAgreements
0.80
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q1 us-gaap Revenues
Revenues
8619000000 USD
CY2019Q1 us-gaap Revenues
Revenues
7828000000 USD

Files In Submission

Name View Source Status
0001551152-20-000015-index-headers.html Edgar Link pending
0001551152-20-000015-index.html Edgar Link pending
0001551152-20-000015.txt Edgar Link pending
0001551152-20-000015-xbrl.zip Edgar Link pending
abbv-20200331.xsd Edgar Link pending
abbv-20200331x10q.htm Edgar Link pending
abbv-20200331x10q_htm.xml Edgar Link completed
abbv-20200331xex101.htm Edgar Link pending
abbv-20200331xex102.htm Edgar Link pending
abbv-20200331xex103.htm Edgar Link pending
abbv-20200331xex104.htm Edgar Link pending
abbv-20200331xex105.htm Edgar Link pending
abbv-20200331xex106.htm Edgar Link pending
abbv-20200331xex21.htm Edgar Link pending
abbv-20200331xex311.htm Edgar Link pending
abbv-20200331xex312.htm Edgar Link pending
abbv-20200331xex321.htm Edgar Link pending
abbv-20200331xex322.htm Edgar Link pending
abbv-20200331_cal.xml Edgar Link unprocessable
abbv-20200331_def.xml Edgar Link unprocessable
abbv-20200331_lab.xml Edgar Link unprocessable
abbv-20200331_pre.xml Edgar Link unprocessable
abbvieimage1a38.jpg Edgar Link pending
abbvieimage2a15.gif Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending